Home › Scleroderma › Louisiana › New Orleans
Scleroderma clinical trials in New Orleans, LA
6 studies for Scleroderma are looking for participants at sites in and around New Orleans (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
RecruitingPhase 3
- DelRicht Research-New Orleans-64100, New Orleans
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
RecruitingPhase 2
- DelRicht Research, LLC, New Orleans
A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
RecruitingPhase 1
- Tulane University Medical Center, New Orleans
The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
Recruiting
- DelRicht Research Center, New Orleans
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
RecruitingPhase 2
- aTyr Investigative Site, New Orleans
New Orleans Pulmonary Hypertension Biobank
RecruitingObservational studyHealthy volunteers welcome
- University Medical Center-New Orleans, New Orleans
About Scleroderma
Scleroderma is an autoimmune disease that causes inflammation and thickening in the skin and other areas of the body. The exact cause of scleroderma is unknown.
More about Scleroderma on MedlinePlus
Scleroderma trials in other cities
- New York City, NY11 studies
- Ann Arbor, MI10 studies
- Chicago, IL10 studies
- Houston, TX9 studies
- Boston, MA7 studies
- Durham, NC7 studies
- Los Angeles, CA7 studies
- Baltimore, MD6 studies
- Philadelphia, PA6 studies
- Dallas, TX5 studies
- Pittsburgh, PA5 studies
- Plantation, FL4 studies
Other studies in New Orleans
- Breast Cancer12 studies
- Cancer (all types)12 studies
- Ovarian Cancer12 studies
- Non-Small Cell Lung Cancer10 studies
- Prostate Cancer10 studies
- Lung Cancer9 studies
- Endometrial Cancer9 studies
- Metastatic Cancer9 studies
- Cardiovascular Disease9 studies
- Obesity8 studies
- Colorectal Cancer8 studies
- Steatotic Liver Disease8 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.